Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Conditions:   Peripheral T-cell Lymphomas;   Lymphoproliferative Disorders;   Immune System Diseases Interventions:   Drug: IOC;   Drug: GVHD prophylaxis;   Drug: RIC;   Procedure: allo HCT Sponsor:   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials